Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices (Q34097755)

31 July 2017

Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices (English)

1 reference

31 July 2017

Jessica P Simons

1

1 reference

31 July 2017

Sing Chau Ng

2

1 reference

31 July 2017

Theodore P McDade

3

1 reference

31 July 2017

Zheng Zhou

4

1 reference

31 July 2017

Craig C Earle

5

1 reference

31 July 2017

Jennifer F Tseng

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

31 July 2017

1 reference

31 July 2017

116

1 reference

31 July 2017

7

1 reference

31 July 2017

1681-1690

1 reference

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Perioperative mortality for pancreatectomy: a national perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Pancreatic cancer in the general population: Improvements in survival over the last decade.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Treatment of Locally Advanced Pancreatic Cancer in the Real World: Population-Based Practices and Effectiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Development of a comorbidity index using physician claims data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

National complication rates after pancreatectomy: beyond mere mortality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24918

7 January 2021

Identifiers

DOI

10.1002/CNCR.24918

1 reference

31 July 2017

1 reference